Global Regulators Synergize Horizon Scanning Efforts
New Network Will Focus On Identifying Potentially Disruptive Technologies
The International Coalition of Medicines Regulatory Authorities has established an innovation network to identify emerging technologies and develop internationally acceptable approaches for their regulation.
You may also be interested in...
Health Canada is inviting suggestions from stakeholders as it works on implementing a flexible approach for authorizing complex and novel health products. The regulator also draws up new clinical trial rules.
A new EU group is keeping a bird's eye view on new innovative medicinal products being brought before member states’ innovation offices, and has flagged up "emerging challenges" and "interesting cases" identified throughout 2017 that need further discussion at the level of the EU medicines network.
The remarkable shift towards decentralized clinical trials in the last three years is a testament to how this patient-centric approach of doing research has the potential to solve multiple issues such as time, cost and low participation rates. In this first segment of a two-part article, Pink Sheet looks at how innovation in this sector has just begun and we can expect more action ahead.